Safeguard Scientifics, Inc. (SFES)

Safeguard Scientifics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2020	2019	2018
Cash & Equivalents	13.36	24.76	15.6	25.05	8.2
Short-Term Investments	5.96	0	0	0	37.96
Cash & Cash Equivalents	19.31	24.76	15.6	25.05	46.16
Cash Growth	-22.02%	58.73%	-37.73%	-45.72%	59.36%
Other Current Assets	2.11	5.51	0.46	1.3	0.58
Total Current Assets	21.42	30.28	16.06	26.35	46.74
Property, Plant & Equipment	1.29	1.56	1.79	2.1	0.81
Long-Term Investments	14.55	21.97	50.4	77.13	95.59
Other Long-Term Assets	0.43	0.22	0.78	2	2.61
Total Long-Term Assets	16.27	23.75	52.97	81.23	99
Total Assets	37.69	54.03	69.04	107.58	145.74
Accounts Payable	0.02	0.04	0.06	0.04	0.17
Current Debt	0.43	0.38	0.33	0.4	27.16
Other Current Liabilities	1.37	1.32	3.09	1.99	5.62
Total Current Liabilities	1.82	1.73	3.47	2.43	32.94
Long-Term Debt	1.25	1.68	2.05	2.38	43.01
Other Long-Term Liabilities	0.05	0.05	0.64	1.03	2.8
Total Long-Term Liabilities	1.3	1.73	2.69	3.41	45.82
Total Liabilities	3.12	3.46	6.16	5.84	78.76
Total Debt	1.68	2.05	2.38	2.78	70.17
Debt Growth	-18.27%	-13.74%	-14.36%	-96.04%	-18.22%
Retained Earnings	-723.9	-709.64	-736.64	-697.22	-731.11
Comprehensive Income	-0.03	-0.03	-0.03	-0.03	0
Shareholders' Equity	34.58	50.57	62.88	101.74	66.98
Net Cash / Debt	17.63	22.71	13.22	22.27	-24.02
Net Cash / Debt Growth	-22.35%	71.78%	-40.64%	-	-
Net Cash Per Share	1.08	1.15	0.64	1.08	-1.17
Working Capital	19.61	28.54	12.59	23.92	13.8
Book Value Per Share	2.12	2.55	3.03	4.93	3.26

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).